The end-stage kidney disease device performed as well in the study as in a pivotal trial that supported FDA approval.
Medtronic confirms paclitaxel balloon’s efficacy in post-approval trial
The end-stage kidney disease device performed as well in the study as in a pivotal trial that supported FDA approval.